LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/MicroPort Launches Procotyl Prime Acetabular Cup
Large Joints and Extremities

MicroPort Launches Procotyl Prime Acetabular Cup

September 12, 2017 2 min read Premium comments

Advertisement

MicroPort Launches Procotyl Prime Acetabular Cup
Procotyl Prime Acetabular Cup System / Courtesy of MicroPort Orthopedics
Secondary

MicroPort Orthopedics, based in Arlington, Tennessee, has launched its Procotyl Prime Acetabular Cup System.

“At MicroPort Orthopedics, we embrace the constant advance in orthopedic medicine, and have a deep commitment to creating products that make patients’ lives better,” said company President Aurelio Sahagun, in the company’s August 29, 2017 news release. “The Procotyl Prime Acetabular Cup System, with its best-in-class features, is a great example of this commitment, as it not only strengthens our position as a leader in surgical joint replacement, but also complements our existing products and surgical approaches to help patients return to full function faster.”

“Procotyl Prime’s design is a culmination of over 20 years of market experience coupled with intelligent design and engineering,” said James Chow, M.D., director of Orthopedics Hip & Joint at Phoenix St. Luke’s Medical Center. “We set out to design an implant optimized for highly-crosslinked polyethylene and modern 3D fixation surfaces, allowing us to eliminate compromises. The result is a shell that is strong and flexible, has maximized poly thickness and robust pull-out strength, all while allowing the versatility of large head options in the smallest sizes.”

Brad Penenberg, M.D., chief of Arthroplasty Service at Cedars-Sinai Hospital, said, “Procotyl Prime is the first acetabular component adapted for MicroPort’s novel portal-assisted acetabular instrumentation. This unique approach facilitates preservation of soft tissue, fast patient recovery, and direct acetabular visualization.”

Sahagun told OTW, “MicroPort Orthopedics has a deep commitment to creating products that make patients’ lives better and we embrace the knowledge and surgical advancements made in orthopedic medicine. By listening to what surgeons were asking for, and what they needed, our development team’s design and engineering expertise resulted in a product that truly stands to benefit not only the physicians performing the surgery, but also the patients who receive it. The Procotyl Prime system is a culmination of over 20 years of market experience. It was fantastic seeing the hard work and passion the team and the surgeons brought forth every day to make it a reality for the patients.”

“Surgeons will likely be most excited that Procotyl Prime is the first system designed with simple, versatile instrumentation to support a variety of approaches that facilitate preservation of soft tissue, fast patient recovery, and direct acetabular visualization. The system is also optimized for highly cross-linked polyethylene bearings and modern fixation surfaces, eliminating any potential design compromises associated with other bearing surfaces. We are truly proud of this product because it lives up to the MicroPort Orthopedics mantra of helping patients return to full function, faster.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy